Reciprocal interferences of the left ventricular assist device and the aortic valve competence

被引:5
作者
Vriz, Olga [1 ]
Mushtaq, Ali [2 ]
Shaik, Abdullah [2 ]
El-Shaer, Ahmed [2 ]
Feras, Khalid [1 ]
Eltayeb, Abdalla [1 ]
Alsergnai, Hani [1 ]
Kholaif, Naji [1 ]
Al Hussein, Mosaad [1 ]
Albert-Brotons, Dimpna [1 ]
Simon, Andre Rudiger [1 ]
Tsai, Felix Wang [1 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Heart Ctr Dept, Riyadh, Saudi Arabia
[2] Alfaisal Univ, Sch Med, Riyadh, Saudi Arabia
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2023年 / 9卷
关键词
heart transplant; left ventricular assist device (LVAD); aortic regurgitation; transcatheter aortic valve implantation (TAVI); surgical intervention; END-STAGE HEART; CONTINUOUS-FLOW; PULSATILE-FLOW; INTERNATIONAL SOCIETY; INTERMACS ANALYSIS; AMERICAN SOCIETY; BLOOD-FLOW; INSUFFICIENCY; SUPPORT; FAILURE;
D O I
10.3389/fcvm.2022.1094796
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients suffering from end-stage heart failure tend to have high mortality rates. With growing numbers of patients progressing into severe heart failure, the shortage of available donors is a growing concern, with less than 10% of patients undergoing cardiac transplantation (CTx). Fortunately, the use of left ventricular assist devices (LVADs), a variant of mechanical circulatory support has been on the rise in recent years. The expansion of LVADs has led them to be incorporated into a variety of clinical settings, based on the goals of therapy for patients ailing from heart failure. However, with an increase in the use of LVADs, there are a host of complications that arise with it. One such complication is the development and progression of aortic regurgitation (AR) which is noted to adversely influence patient outcomes and compromise pump benefits leading to increased morbidity and mortality. The underlying mechanisms are likely multifactorial and involve the aortic root-aortic valve (AV) complex, as well as the LVAD device, patient, and other factors, all of them alter the physiological mechanics of the heart resulting in AV dysfunction. Thus, it is imperative to screen patients before LVAD implantation for AR, as moderate or greater AR requires a concurrent intervention at the time of LVADs implantation. No current strict guidelines were identified in the literature search on how to actively manage and limit the development and/or progression of AR, due to the limited information. However, some recommendations include medical management by targeting fluid overload and arterial blood pressure, along with adjusting the settings of the LVADs device itself. Surgical interventions are to be considered depending on patient factors, goals of care, and the underlying pathology. These interventions include the closure of the AV, replacement of the valve, and percutaneous approach via percutaneous occluding device or transcatheter aortic valve implantation. In the present review, we describe the interaction between AV and LVAD placement, in terms of patient management and prognosis. Also it is provided a comprehensive echocardiographic strategy for the precise assessment of AV regurgitation severity.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Simultaneous aortic valve replacement in left ventricular assist device recipients: single-center experience
    Dranishnikov, Nikolay
    Stepanenko, Alexander
    Potapov, Evgenij V.
    Dandel, Michael
    Siniawski, Henryk
    Mladenow, Alexander
    Huebler, Michael
    Grauhan, Onnen
    Weng, Yuguo
    Krabatsch, Thomas
    Hetzer, Roland
    Kukucka, Marian
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2012, 35 (07) : 489 - 494
  • [32] Percutaneous Closure of Aortic Valve Complicated by Right Ventricular Failure in a Patient With Left Ventricular Assist Device
    Guvenc, Tolga Sinan
    Ertas, Gokhan
    Sargin, Murat
    ARTIFICIAL ORGANS, 2016, 40 (04) : 416 - 418
  • [33] Percutaneous Closure of an Incompetent Aortic Valve Using an Occluder Device in a Patient with Left Ventricular Assist Device
    Feider, Andrew
    Dhawan, Richa
    Chaney, Mark
    ANESTHESIA AND ANALGESIA, 2013, 117 (05) : 1078 - 1080
  • [34] Modeling Aortic Valve Closure under the Action of a Ventricular Assist Device
    Alonazi, Khalid A.
    Savkin, Andrey V.
    Lovell, Nigel H.
    Dokos, Socrates
    2013 35TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2013, : 679 - 682
  • [35] In Vitro Evaluation of Aortic Insufficiency With a Rotary Left Ventricular Assist Device
    Gregory, Shaun D.
    Stevens, Michael C.
    Wu, Eric
    Fraser, John F.
    Timms, Daniel
    ARTIFICIAL ORGANS, 2013, 37 (09) : 802 - 809
  • [36] Aortic regurgitation in patients with a left ventricular assist device: A contemporary review
    Bouabdallaoui, Nadia
    El-Hamamsy, Ismail
    Pham, Magali
    Giraldeau, Genevieve
    Parent, Marie-Claude
    Carrier, Michel
    Rouleau, Jean L.
    Ducharme, Anique
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (11) : 1289 - 1297
  • [37] Insertion of an Abiomed Impella® Left Ventricular Assist Device Following Bioprosthetic Aortic Valve Placement
    Thomas, Matthew P.
    Altman, Ashley
    Magovern, George J., Jr.
    Moraca, Robert J.
    JOURNAL OF CARDIAC SURGERY, 2013, 28 (04) : 469 - 471
  • [38] Transcatheter aortic valve replacement thrombosis in patient supported with durable left ventricular assist device
    Rao, Sriram D.
    Jagasia, Dinesh
    Anwaruddin, Saif
    Birati, Edo Y.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 96 (02) : 500 - 503
  • [39] Complete Aortic Valve Fusion After HeartMate II Left Ventricular Assist Device Support
    Gallen, Thomas Brent
    Lau, William Travis
    Mehta, Anand R.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2012, 26 (06) : 1060 - 1062
  • [40] Transfemoral aortic valve replacement prior to HeartMate II left ventricular assist device exchange
    Sharma, Shashank
    Tchantchaleishvili, Vakhtang
    Briasoulis, Alexandros
    Joyce, David L.
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2017, 25 (01) : 157 - 159